EUVIMEDEUVIMED entdecken
Crossref

Computational Screening of Inhibitory Compounds for SARS-Cov-2 3CL Protease with a Database Consisting of Approved and Investigational Chemicals

Kazunori Miwa, Yan Guo, Masayuki Hata, Norio Yamamoto, Tyuji Hoshino

Chemical and Pharmaceutical Bulletin · 01.05.2023 · 71 (5) · 360-367

DOI: 10.1248/cpb.c23-00035 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical and Pharmaceutical Bulletin, erschienen am 01.05.2023. Verfasst von Kazunori Miwa und 4 weiteren Autor:innen. Beteiligte Einrichtung: Graduate School of Pharmaceutical Sciences, Chiba University. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Computational screening is one of the fundamental techniques in drug discovery. Each compound in a chemical database is bound to the target protein in virtual, and candidate compounds are selected from the binding scores. In this work, we carried out combinational computation of docking simulation to generate binding poses and molecular mechanics calculation to estimate binding scores. The coronavirus infectious disease has spread worldwide, and effective chemotherapy is strongly required. The viral 3-chymotrypsin-like (3CL) protease is a good target of low molecular-weight inhibitors. Hence, computational screening was performed to search for inhibitory compounds acting on the 3CL protease. As a preliminary assessment of the performance of this approach, we used 51 compounds for which inhibitory activity had already been confirmed. Docking simulations and molecular mechanics calculations were performed to evaluate binding scores. The preliminary evaluation suggested that our approach successfully selected the inhibitory compounds identified by the experiments. The same approach was applied to 8820 compounds in a database consisting of approved and investigational chemicals. Hence, docking simulations, molecular mechanics calculations, and re-evaluation of binding scores including solvation effects were performed, and the top 200 poses were selected as candidates for experimental assays. Consequently, 25 compounds were chosen for in vitro measurement of the enzymatic inhibitory activity. From the enzymatic assay, 5 compounds were identified to have inhibitory activities against the 3CL protease. The present work demonstrated the feasibility of a combination of docking simulation and molecular mechanics calculation for practical use in computational virtual screening.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansPeptide HydrolasesProtease InhibitorsViral Nonstructural ProteinsCysteine EndopeptidasesMolecular Dynamics SimulationMolecular Docking SimulationAntiviral Agents

Stichwörter der Autor:innen

3-chymotrypsin-like (3CL) proteasecomputational screeningdocking simulationinhibitormolecular mechanics calculationsevere acute respiratory syndrome coronavirus 2 (SARS-Cov-2)

Substanzen

Peptide HydrolasesProtease InhibitorsViral Nonstructural ProteinsCysteine EndopeptidasesAntiviral Agents

Autor:innen und Institutionen

  • Graduate School of Pharmaceutical Sciences, Chiba University.
  • Faculty of Pharmaceutical Sciences, Matsuyama University.
  • Department of Virology, Division of Host Defense Mechanism, Tokai University School of Medicine.

Zitieren

APA

Miwa, K., Guo, Y., Hata, M., Yamamoto, N., & Hoshino, T. (2023). Computational Screening of Inhibitory Compounds for SARS-Cov-2 3CL Protease with a Database Consisting of Approved and Investigational Chemicals. Chemical and Pharmaceutical Bulletin, 71(5), 360-367. https://doi.org/10.1248/cpb.c23-00035

Vancouver

Miwa K, Guo Y, Hata M, Yamamoto N, Hoshino T. Computational Screening of Inhibitory Compounds for SARS-Cov-2 3CL Protease with a Database Consisting of Approved and Investigational Chemicals. Chemical and Pharmaceutical Bulletin. 2023;71(5):360-367. doi:10.1248/cpb.c23-00035

BibTeX
@article{Miwa2023,
  author = {Miwa, Kazunori and Guo, Yan and Hata, Masayuki and Yamamoto, Norio and Hoshino, Tyuji},
  title = {Computational Screening of Inhibitory Compounds for SARS-Cov-2 3CL Protease with a Database Consisting of Approved and Investigational Chemicals},
  journal = {Chemical and Pharmaceutical Bulletin},
  year = {2023},
  volume = {71},
  number = {5},
  pages = {360--367},
  doi = {10.1248/cpb.c23-00035}
}
Kostenlos starten →